Sapru Anil, Liu Kathleen D, Wiemels Joseph, Hansen Helen, Pawlikowska Ludmilla, Poon Annie, Jorgenson Eric, Witte John S, Calfee Carolyn S, Ware Lorraine B, Matthay Michael A
Departments of Pediatrics, University of California, Box 0106, , 550, 16th Street, San Francisco, CA, 94143, USA.
David Geffen School of Medicine, Department of Pediatrics, University of California, 10833 Le Conte Avenue, 12-488 MDCC, Los Angeles, 90095, CA, USA.
Crit Care. 2016 May 23;20(1):151. doi: 10.1186/s13054-016-1330-5.
Altered plasma levels of protein C, thrombomodulin, and the endothelial protein C receptor are associated with poor clinical outcomes in patients with acute respiratory distress syndrome (ARDS). We hypothesized that common variants in these genes would be associated with mortality as well as ventilator-free and organ failure-free days in patients with ARDS.
We genotyped linkage disequilibrium-based tag single-nucleotide polymorphisms in the ProteinC, Thrombomodulin and Endothelial Protein C Reptor Genes among 320 self-identified white patients of European ancestry from the ARDS Network Fluid and Catheter Treatment Trial. We then tested their association with mortality as well as ventilator-free and organ-failure free days.
The GG genotype of rs1042580 (p = 0.02) and CC genotype of rs3716123 (p = 0.002), both in the thrombomodulin gene, and GC/CC genotypes of rs9574 (p = 0.04) in the endothelial protein C receptor gene were independently associated with increased mortality. An additive effect on mortality (p < 0.001), ventilator-free days (p = 0.01), and organ failure-free days was observed with combinations of these high-risk genotypes. This association was independent of age, severity of illness, presence or absence of sepsis, and treatment allocation.
Genetic variants in thrombomodulin and endothelial protein C receptor genes are additively associated with mortality in ARDS. These findings suggest that genetic differences may be at least partially responsible for the observed associations between dysregulated coagulation and poor outcomes in ARDS.
急性呼吸窘迫综合征(ARDS)患者血浆中蛋白C、血栓调节蛋白和内皮蛋白C受体水平的改变与不良临床结局相关。我们推测这些基因的常见变异与ARDS患者的死亡率以及无呼吸机天数和无器官衰竭天数相关。
我们对急性呼吸窘迫综合征网络液体和导管治疗试验中320名自我认定为欧洲血统的白人患者的蛋白C、血栓调节蛋白和内皮蛋白C受体基因中基于连锁不平衡的标签单核苷酸多态性进行了基因分型。然后我们测试了它们与死亡率以及无呼吸机天数和无器官衰竭天数的关联。
血栓调节蛋白基因中的rs1042580的GG基因型(p = 0.02)和rs3716123的CC基因型(p = 0.002),以及内皮蛋白C受体基因中的rs9574的GC/CC基因型(p = 0.04)均与死亡率增加独立相关。这些高危基因型的组合对死亡率(p < 0.001)、无呼吸机天数(p = 0.01)和无器官衰竭天数有累加效应。这种关联独立于年龄、疾病严重程度、是否存在脓毒症以及治疗分配。
血栓调节蛋白和内皮蛋白C受体基因的遗传变异与ARDS患者的死亡率呈累加相关。这些发现表明遗传差异可能至少部分导致了ARDS中凝血失调与不良结局之间观察到的关联。